Viewing Study NCT01692756



Ignite Creation Date: 2024-05-06 @ 12:57 AM
Last Modification Date: 2024-10-26 @ 10:56 AM
Study NCT ID: NCT01692756
Status: COMPLETED
Last Update Posted: 2018-12-05
First Post: 2012-09-11

Brief Title: Early Treatment for Acute ACL Tear
Sponsor: Cale Jacobs
Organization: University of Kentucky

Study Overview

Official Title: Early Anti-inflammatory Treatment in Patients With Acute ACL Tear
Status: COMPLETED
Status Verified Date: 2018-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: AAA
Brief Summary: This research study is the first of its kind and will allow health care professionals and researchers to answer many questions about the reasons why anterior cruciate ligament ACL injury leads to knee pain and disability and osteoarthritis We also hope that this study will be the beginning of new more powerful and safer drugs to help patients with ACL injuries heal sooner and return to sports or daily activities pain free Study participants will be recruited from the University of Kentucky and Vanderbilt University

The purpose of this research is to gather information on how safe and effective Kenalog is in alleviating knee pain following ACL rupture
Detailed Description: Injury to the knee during sports participation often involves partial of full detachment of the ACL ACL tears cause pain swelling and inflammation While the swelling and inflammation usually goes away in time individuals with ACL injuries may experience pain and notice knee instability knee slipping etc Often surgery can repair or replace the ACL within the joint allowing individuals the ability to walk or run again pain free or participate in sports Unfortunately osteoarthritis of the knee which also causes pain and swelling can occur in that same knee 10-20 years later for reasons which are not well understood

In this research study we hope to prevent and reduce the initial post-operative pain The reduction of pain will allow for earlier movement of the knee joint and preparation for surgery It may also reduce the risk to develop osteoarthritis in individuals with ACL injuries by treating them within 1-2 days after their injury

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None